Featured Research

from universities, journals, and other organizations

Boosting Survival Of Insulin-cell Transplants For Type 1 Diabetes

Date:
July 9, 2008
Source:
American Chemical Society
Summary:
Researchers in Japan are reporting a discovery that could improve the effectiveness and expand the use of transplants of insulin-producing cells to treat diabetes. Insulin-dependent, or Type 1, diabetes affects about 800,000 people in the United States.

Scientists have developed a process that could could improve transplants of insulin-producing cells for treating diabetes. The new method prevents destruction of those cells by coating them with heparin.
Credit: Courtesy of the American Chemical Society

Researchers in Japan are reporting a discovery that could improve the effectiveness and expand the use of transplants of insulin-producing cells to treat diabetes. Insulin-dependent, or Type 1, diabetes affects about 800,000 people in the United States.

Related Articles


In the new study, Yuji Teramura and Hiroo Iwata point out that transplantation of the pancreas's insulin producing cells, so-called islets of Langerhans, is a promising experimental technique for treating patients with insulin-dependent diabetes.

However, the procedure is not sufficiently effective for many people. This is because the body destroys many of the islet cells right after transplantation in an inflammatory reaction triggered by blood clotting on the surface of the cells, the researchers say.

To address this problem, the scientists coated islet cells with a special polymer film containing heparin, an anticoagulant, or urokinase, a medication that dissolves blood clots. In laboratory studies, the researchers showed that the coatings delayed the clotting long enough to prevent the destruction that otherwise would occur immediately after transplantation.

The coatings did not affect the ability of the cells to produce insulin, the researchers add.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Teramura et al. Islets Surface Modification Prevents Blood-Mediated Inflammatory Responses. Bioconjugate Chemistry, 2008; 0 (0): 0 DOI: 10.1021/bc800064t

Cite This Page:

American Chemical Society. "Boosting Survival Of Insulin-cell Transplants For Type 1 Diabetes." ScienceDaily. ScienceDaily, 9 July 2008. <www.sciencedaily.com/releases/2008/07/080707091309.htm>.
American Chemical Society. (2008, July 9). Boosting Survival Of Insulin-cell Transplants For Type 1 Diabetes. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2008/07/080707091309.htm
American Chemical Society. "Boosting Survival Of Insulin-cell Transplants For Type 1 Diabetes." ScienceDaily. www.sciencedaily.com/releases/2008/07/080707091309.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Nurse Nina Pham Cured of Ebola

Texas Nurse Nina Pham Cured of Ebola

AFP (Oct. 25, 2014) — An American nurse who contracted Ebola while caring for a Liberian patient in Texas has been declared free of the virus and will leave the hospital. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins